Medtronic launches newest-generation drug coated balloon catheter in europe for treatment of coronary artery disease

Medtronic prevail dcb™ designed to treat complex lesions with superior deliverability, rapid absorption of paclitaxel dublin, july 26, 2021 /prnewswire/ -- medtronic plc (nyse: mdt), the global leader in medical technology, today announced the launch of the prevail™ drug coated balloon (dcb) catheter in europe following ce (conformitÉ europÉene) mark. the newest coronary dcb on the market, the prevail dcb is used during percutaneous coronary intervention (pci) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (cad).
MDT Ratings Summary
MDT Quant Ranking